Journal Article

IV.5.2 Arterial hypertension

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue suppl_4, pages 25-26
Published in print April 2002 | ISSN: 0931-0509
Published online April 2002 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/17.suppl_4.25
IV.5.2 Arterial hypertension

Show Summary Details

Preview

Guidelines

A. Arterial hypertension is often present after renal transplantation and is of multifactorial origin. Pre‐transplant arterial hypertension, chronic allograft nephropathy and immunosuppressive therapy are the most frequent causes of post‐transplant arterial hypertension. Careful monitoring and treatment of high blood pressure are recommended following transplantation.

(Evidence level B)

B. Post‐transplant arterial hypertension is associated with an increased incidence of cardiovascular disease in renal transplant patients and is an independent risk factor for graft failure. Therefore, blood pressure control (<130/85 mmHg for renal transplant recipients without proteinuria, and <125/75 mmHg for proteinuric patients) is mandatory in these patients. General measures and pharmacological intervention are necessary in many cases. In proteinuric patients, anti‐hypertensive and anti‐proteinuric agents could be used, and stricter blood pressure control is recommended.

(Evidence level C)

C. In patients with uncontrolled arterial hypertension and/or renal function deterioration, underlying causes should be excluded, especially transplant renal artery stenosis.

(Evidence level C)

Journal Article.  0 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.